Adverse drug event profile associated with pregabalin among patients with and without cancer: analysis of a spontaneous reporting database.
Eiji KosePublished in: Journal of clinical pharmacy and therapeutics (2018)
The ADE profiles of pregabalin were broadly similar among patients with and without cancer, but time-to-onset and type of some ADEs may be different.